Combinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro

scientific article published on September 2007

Combinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3346/JKMS.2007.22.S.S52
P8608Fatcat IDrelease_jk2qsifecrbrde7ghjom2inyny
P932PMC publication ID2694387
P698PubMed publication ID17923756
P5875ResearchGate publication ID5920806

P50authorYeul Hong KimQ98617374
P2093author name stringHyun Jin Kim
Eun Jung Choi
Seok Jin Kim
Young Mi Whang
P2860cites workTherapeutic effects of the combination of fenretinide and all-trans-retinoic acid and of the two retinoids with cisplatin in a human ovarian carcinoma xenograft and in a cisplatin-resistant sub-line.Q53682893
Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl) retinamideQ60997520
Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neckQ68537067
Phase II trial of all-trans retinoic acid in metastatic non-small cell lung cancerQ71556856
N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epitheliumQ74216044
Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cellsQ74530097
9-cis retinoic acid is a high affinity ligand for the retinoid X receptorQ28119031
Early effects of retinoic acid on proliferation, differentiation and apoptosis in non-small cell lung cancer cell linesQ28372007
The RXR heterodimers and orphan receptorsQ29547867
Cellular response to oxidative stress: signaling for suicide and survivalQ34138566
N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cellsQ34594976
Retinoids--"differentiation agents" for cancer treatment and preventionQ35237425
13-cis-retinoic acid and cancer chemopreventionQ35356441
Molecularly targeted approaches to the chemoprevention of lung cancerQ35817534
Retinoids and their receptors in differentiation, embryogenesis, and neoplasiaQ36448344
Retinoids as modulators of tumor cells invasion and metastasisQ37363118
Studies of synergistic and antagonistic combinations of conventional cytotoxic agents with the multiple eicosanoid pathway modulator LY 293111.Q40509177
Retinoids and cancer: a basis for differentiation therapyQ40860954
Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms.Q40951916
Secretion of N-(4-hydroxyphenyl) retinamide-retinol-binding protein from liver parenchymal cells: evidence for reduced affinity of the complex for transthyretinQ41109859
Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expressionQ41229162
9-cis-Retinoic acid inhibition of lung carcinogenesis in the A/J mouse model is accompanied by increased expression of RAR-beta but no change in cyclooxygenase-2.Q42167563
Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2.Q42280130
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancerQ43579847
Antiproliferative mechanism of retinoid derivatives in ovarian cancer cellsQ43786672
Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?Q44068904
Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trialQ44303836
N-(4-hydroxyphenyl)-retinamide selectively increases All-TRANS retinoic acid inhibitory effects in HER2/NEU-overexpressing breast cancer cellsQ44321643
Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.Q44471521
Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.Q44615083
4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptorsQ46690362
Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell linesQ48024992
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjecttretinoinQ29417
lung carcinomaQ18556110
P304page(s)S52-60
P577publication date2007-09-01
P1433published inJournal of Korean Medical ScienceQ24039955
P1476titleCombinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro
P478volume22 Suppl

Reverse relations

cites work (P2860)
Q43193914All-Trans Retinoic Acid Induces Proliferation, Survival, and Migration in A549 Lung Cancer Cells by Activating the ERK Signaling Pathway through a Transcription-Independent Mechanism.
Q39583349Characterization and functional analysis of the human microRNA let-7a2 promoter in lung cancer A549 cell lines
Q45534828Preparation and in vitro characterization of retinoic acid-loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) micelles
Q89510543Retinoic Acids in the Treatment of Most Lethal Solid Cancers
Q41573464Synergistic effect of fenretinide and curcumin for treatment of non-small cell lung cancer.
Q93121747The potential of retinoids for combination therapy of lung cancer: Updates and future directions
Q28261714The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer

Search more.